Janssen

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.

History

Janssen Pharmaceutica was established in 1953 by Paul Janssen, a Belgian doctor who had a passion for pharmacology. The company was originally a part of the N.V. Produkten Richter in Turnhout. In 1956, Paul Janssen developed his first drug, Neomeritine, an antispasmodic found to have analgesic properties. In 1961, the company was acquired by the American corporation, Johnson & Johnson.

Products

Janssen Pharmaceutica has developed and produced a variety of pharmaceutical products, including antipsychotic, antiviral, antifungal, and antiparasitic drugs. Some of their most notable products include Risperdal, Prezista, and Remicade.

Research and Development

Janssen Pharmaceutica is known for its strong commitment to Research and Development. The company invests heavily in R&D, with a focus on areas such as neuroscience, oncology, immunology, infectious diseases, and vaccines.

Controversies

Janssen Pharmaceutica has been involved in several controversies, including allegations of unethical marketing practices and lawsuits related to the side effects of some of its drugs.

See Also

• Johnson & Johnson
• Pharmaceutical industry in Belgium
• List of pharmaceutical companies

External Links

• Official website

Janssen Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski